Lab
Universal Genetics LLC
Universal Genetics LLC was paid $181K by Medicaid between Jan 2021 and Jun 2023, across 5 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 40% of everything it billed.
33Billing provider infoUNIVERSAL GENETICS LLC
MONROVIA, CA 91016
MONROVIA, CA 91016
33aNPI1477157725assigned 11/27/2020
33bProvider typeClinical Medical Laboratory
28Total paid$181K
24GClaims6,388
24DCodes billed5
24AFirst – last monthJan 2021 – Jun 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#288 of 561
Median peer was paid$222K
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,677 | $45K | |
| 2022 | 2,424 | $122K | |
| 2023 | 2,287 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 40% | 816 | 598 | $72K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 35% | 1,093 | 857 | $62K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 15% | 1,732 | 1,383 | $27K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 7.5% | 2,287 | 2,235 | $14K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.1% | 460 | 381 | $6K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKU, DAVID (MEDICAL DIRECTOR)